cytosine has been researched along with Stomach Neoplasms in 19 studies
Stomach Neoplasms: Tumors or cancer of the STOMACH.
Excerpt | Relevance | Reference |
---|---|---|
"Under study was the nucleotide content and the level of methylated cytosine (5-MC) in the DNA, isolated from adenocarcinoma of the stomach, gastric mucosa in patients with duodenal ulcer as well as from the mucosa of intact human stomach." | 3.66 | [Nucleotide composition and the methylated cytosine level in the DNA from a cancerous stomach tumor]. ( Kliasheva, RI; Panfilova, GA; Volkov, VE, 1980) |
"Here we show that, in gastric cancers, the 5 hmC decrease correlates with a decrease in ten-eleven translocation 1 (TET1) expression, which is strongly associated with metastasis and poor survival in patients with gastric cancer." | 1.42 | Decrease of 5hmC in gastric cancers is associated with TET1 silencing due to with DNA methylation and bivalent histone marks at TET1 CpG island 3'-shore. ( Choi, BY; Kang, GH; Kim, HJ; Kim, M; Kim, SY; Kim, YS; Kwon, OH; Lim, B; Park, JL; Seo, EH; Song, KS, 2015) |
"The study population included 177 gastric cancer patients and 224 healthy control subjects." | 1.33 | A single nucleotide polymorphism in the MMP-9 promoter affects tumor progression and invasive phenotype of gastric cancer. ( Chayama, K; Imai, K; Kitadai, Y; Matsumura, S; Matsusaki, K; Nakachi, K; Nakayama, H; Oue, N; Yamaguchi, Y; Yasui, W; Yoshida, K, 2005) |
"Lymphocyte genomic DNA from 134 Italian gastric cancer patients and 139 controls was used for genotyping two polymorphisms in the TS 5'-untranslated region (5'-UTR); a double (2R) or triple (3R) 28-bp repeat and a G/C polymorphism within the triple repeats allele (3G allele)." | 1.32 | Association of thymidylate synthase polymorphisms with gastric cancer susceptibility. ( Bearzi, I; Cascinu, S; Catalano, V; Ficarelli, R; Graziano, F; Humar, B; Kawakami, K; Magnani, M; Merriman, T; Panunzi, S; Ruzzo, A; Santini, D; Testa, E; Tonini, G; Watanabe, G, 2004) |
"About 80% of the gastric cancer showed a high level of expression of cyclooxygenase 2, but a subset of cases do not express without unknown reason." | 1.31 | Aberrant methylation and histone deacetylation of cyclooxygenase 2 in gastric cancer. ( Fujita, M; Hosokawa, M; Imai, K; Itoh, F; Kikuchi, T; Suzuki, H; Toyota, M; Yamamoto, H, 2002) |
"Methylation of hMLH1 promoter from a colorectal cancer cell line RKO and a gastric cancer cell line PACM82 was analyzed by DHPLC." | 1.31 | [Analysis of the methylation in CpG island by denaturing high-performance liquid chromatography]. ( Deng, D; Deng, G; Lü, Y, 2001) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (10.53) | 18.7374 |
1990's | 3 (15.79) | 18.2507 |
2000's | 7 (36.84) | 29.6817 |
2010's | 6 (31.58) | 24.3611 |
2020's | 1 (5.26) | 2.80 |
Authors | Studies |
---|---|
Ahmadi Hedayati, M | 1 |
Ahmadi, A | 1 |
Khatooni, Z | 1 |
Yang, Q | 1 |
Wu, K | 1 |
Ji, M | 1 |
Jin, W | 1 |
He, N | 1 |
Shi, B | 1 |
Hou, P | 2 |
Fu, HL | 1 |
Ma, Y | 1 |
Lu, LG | 1 |
Li, BJ | 1 |
Jin, WL | 1 |
Cui, DX | 1 |
Du, C | 1 |
Kurabe, N | 1 |
Matsushima, Y | 1 |
Suzuki, M | 2 |
Kahyo, T | 1 |
Ohnishi, I | 1 |
Tanioka, F | 1 |
Tajima, S | 1 |
Goto, M | 1 |
Yamada, H | 1 |
Tao, H | 1 |
Shinmura, K | 1 |
Konno, H | 1 |
Sugimura, H | 1 |
Park, JL | 1 |
Kim, HJ | 2 |
Seo, EH | 1 |
Kwon, OH | 1 |
Lim, B | 1 |
Kim, M | 1 |
Kim, SY | 1 |
Song, KS | 1 |
Kang, GH | 1 |
Choi, BY | 1 |
Kim, YS | 1 |
Chou, NH | 1 |
Tsai, CY | 1 |
Tu, YT | 1 |
Wang, KC | 1 |
Kang, CH | 1 |
Chang, PM | 1 |
Li, GC | 1 |
Lam, HC | 1 |
Liu, SI | 1 |
Tsai, KW | 1 |
Yan, L | 1 |
Yanan, D | 1 |
Donglan, S | 1 |
Na, W | 1 |
Rongmiao, Z | 1 |
Zhifeng, C | 1 |
Kudo, Y | 1 |
Tateishi, K | 1 |
Yamamoto, K | 1 |
Yamamoto, S | 1 |
Asaoka, Y | 1 |
Ijichi, H | 1 |
Nagae, G | 1 |
Yoshida, H | 1 |
Aburatani, H | 1 |
Koike, K | 1 |
Ashcroft, FJ | 1 |
Varro, A | 1 |
Dimaline, R | 1 |
Dockray, GJ | 1 |
Graziano, F | 1 |
Kawakami, K | 1 |
Watanabe, G | 1 |
Ruzzo, A | 1 |
Humar, B | 1 |
Santini, D | 1 |
Catalano, V | 1 |
Ficarelli, R | 1 |
Merriman, T | 1 |
Panunzi, S | 1 |
Testa, E | 1 |
Cascinu, S | 1 |
Bearzi, I | 1 |
Tonini, G | 1 |
Magnani, M | 1 |
Matsumura, S | 1 |
Oue, N | 1 |
Nakayama, H | 1 |
Kitadai, Y | 1 |
Yoshida, K | 1 |
Yamaguchi, Y | 1 |
Imai, K | 2 |
Nakachi, K | 1 |
Matsusaki, K | 1 |
Chayama, K | 1 |
Yasui, W | 1 |
Akimov, AA | 1 |
Lazarev, NV | 1 |
Kliasheva, RI | 1 |
Volkov, VE | 1 |
Panfilova, GA | 1 |
Kodama, E | 1 |
Shigeta, S | 1 |
Suzuki, T | 1 |
De Clercq, E | 1 |
Hanaoka, K | 1 |
Kobayashi, T | 1 |
Tanzawa, F | 1 |
Tanaka, K | 1 |
Shibayama, T | 1 |
Miura, S | 1 |
Ikeda, T | 1 |
Iwabuchi, H | 1 |
Nakagawa, A | 1 |
Mitsuhashi, Y | 1 |
Hisaoka, M | 1 |
Kaneko, M | 1 |
Tomida, A | 1 |
Wataya, Y | 1 |
Nomura, T | 1 |
Sasaki, T | 1 |
Matsuda, A | 1 |
Tsuruo, T | 1 |
Kurakata, S | 1 |
Tamura, G | 1 |
Yin, J | 1 |
Wang, S | 1 |
Fleisher, AS | 1 |
Zou, T | 1 |
Abraham, JM | 1 |
Kong, D | 1 |
Smolinski, KN | 1 |
Wilson, KT | 1 |
James, SP | 1 |
Silverberg, SG | 1 |
Nishizuka, S | 1 |
Terashima, M | 1 |
Motoyama, T | 1 |
Meltzer, SJ | 1 |
Kikuchi, T | 1 |
Itoh, F | 1 |
Toyota, M | 1 |
Suzuki, H | 1 |
Yamamoto, H | 1 |
Fujita, M | 1 |
Hosokawa, M | 1 |
Deng, D | 1 |
Deng, G | 1 |
Lü, Y | 1 |
Novikov, LB | 1 |
Fedorov, SN | 1 |
Iatsuk, OS | 1 |
Levanova, GI | 1 |
Kalinovskiĭ, VP | 1 |
Khanson, KP | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Observational Study on the Investigation of the Molecular Mechanism and Clinical Significance of the Interplay Between Twist1 and Other EMT Regulators Through microRNA-29 Family.[NCT01927354] | 100 participants (Anticipated) | Observational | 2012-12-31 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
19 other studies available for cytosine and Stomach Neoplasms
Article | Year |
---|---|
DNMT1 Gene Expression in Patients with
Topics: Adenocarcinoma; Antigens, Bacterial; Bacterial Proteins; Case-Control Studies; Cytosine; DNA, Comple | 2022 |
Decreased 5-hydroxymethylcytosine (5-hmC) is an independent poor prognostic factor in gastric cancer patients.
Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; China; Cytosine; Female; Humans | 2013 |
TET1 exerts its tumor suppressor function by interacting with p53-EZH2 pathway in gastric cancer.
Topics: 5-Methylcytosine; Animals; Biomarkers, Tumor; Cell Line, Tumor; Cell Proliferation; Cytosine; Dioxyg | 2014 |
Robust quantitative assessments of cytosine modifications and changes in the expressions of related enzymes in gastric cancer.
Topics: 5-Methylcytosine; Aged; Chromatography, Liquid; Cytosine; Deoxycytidine; Dioxygenases; DNA-Binding P | 2015 |
Decrease of 5hmC in gastric cancers is associated with TET1 silencing due to with DNA methylation and bivalent histone marks at TET1 CpG island 3'-shore.
Topics: 3' Untranslated Regions; 5-Methylcytosine; Chromatin Immunoprecipitation; CpG Islands; Cytosine; DNA | 2015 |
Isocitrate Dehydrogenase 2 Dysfunction Contributes to 5-hydroxymethylcytosine Depletion in Gastric Cancer Cells.
Topics: 5-Methylcytosine; Cytosine; DNA Methylation; Female; Humans; Isocitrate Dehydrogenase; Ketoglutaric | 2016 |
Polymorphisms of XRCC1 gene and risk of gastric cardiac adenocarcinoma.
Topics: Adenine; Adenocarcinoma; Adult; Aged; Arginine; Cardia; Case-Control Studies; Codon; Cytosine; DNA R | 2009 |
Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation.
Topics: 5-Methylcytosine; Cell Line, Tumor; Cell Transformation, Neoplastic; Colorectal Neoplasms; Cytosine; | 2012 |
Control of expression of the lectin-like protein Reg-1 by gastrin: role of the Rho family GTPase RhoA and a C-rich promoter element.
Topics: Animals; Base Sequence; Binding Sites; Cytokines; Cytosine; DNA-Binding Proteins; Enzyme Activation; | 2004 |
Association of thymidylate synthase polymorphisms with gastric cancer susceptibility.
Topics: 3' Untranslated Regions; 5' Untranslated Regions; Adult; Aged; Aged, 80 and over; Case-Control Studi | 2004 |
A single nucleotide polymorphism in the MMP-9 promoter affects tumor progression and invasive phenotype of gastric cancer.
Topics: Aged; Case-Control Studies; Cytosine; Female; Helicobacter Infections; Helicobacter pylori; Humans; | 2005 |
[On the experimental study of stomach ulcer in rats].
Topics: Animals; Cytosine; Male; Pyrimidines; Rats; Stomach Neoplasms; Stomach Ulcer; Thiouracil; Thymine; U | 1966 |
[Nucleotide composition and the methylated cytosine level in the DNA from a cancerous stomach tumor].
Topics: 5-Methylcytosine; Adenocarcinoma; Base Composition; Cytosine; DNA, Neoplasm; Duodenal Ulcer; Gastric | 1980 |
Application of a gastric cancer cell line (MKN-28) for anti-adenovirus screening using the MTT method.
Topics: Adenine; Adenoviruses, Human; Antiviral Agents; Cidofovir; Cytosine; Drug Evaluation, Preclinical; F | 1996 |
Antitumor activity and novel DNA-self-strand-breaking mechanism of CNDAC (1-(2-C-cyano-2-deoxy-beta-D-arabino-pentofuranosyl) cytosine) and its N4-palmitoyl derivative (CS-682).
Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Arabinonucleosides; Biotransformatio | 1999 |
E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas.
Topics: Blotting, Western; Cadherins; Carcinoma; Cytosine; DNA Primers; DNA, Neoplasm; Down-Regulation; Gene | 2000 |
Aberrant methylation and histone deacetylation of cyclooxygenase 2 in gastric cancer.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Azacitidine; Cyclooxygenase 2; Cytosine; Decitabine; DNA | 2002 |
[Analysis of the methylation in CpG island by denaturing high-performance liquid chromatography].
Topics: Adaptor Proteins, Signal Transducing; Carrier Proteins; Chromatography, High Pressure Liquid; Colore | 2001 |
[Determination of the role of DNA cytosine methylation in human genetic individuality].
Topics: Cytosine; DNA; DNA Probes; Genes, ras; Genetic Variation; Humans; Stomach Neoplasms; Stomach Ulcer | 1991 |